Recent studies suggests that the extended or continuous infusion of piperacillin/tazobactam results in lower mortality, a finding that applies for both continuous and extended infusion separately
Nosocomial pneumonia
Complicated intra-abdominal infections
Complicated urinary tract infections
Empiric therapy for febrile neutropenic patients
Skin and soft tissue infections